planning and implementation of an individual
care project including therapeutic interventions aimed at risk reduction, structured educational programs aimed to bring about an effective change of life style (smoking cessation, appropriate diet, weight control, psychological wellbeing), and a prescribed program of physical exercise to reduce the disability consequent from heart disease, improve functional capacity and promote the patient's social and occupational reintegration, plus planning of a followup program aimed at consolidating and maintaining the results and at promoting adherence in the long term.
Despite the large body of scientific evidence documenting the effectiveness of CRP programs in terms of total mortality, cardiovascular mortality, and quality of life, important elements of discrepancy in the real world emerge from a number of major prospective observational studies. In particular, the overall number of cardiac patients who are admitted to a comprehensive CRP program after acute events is unsatisfactory, i.e. less than 30% of those appropriately indicated for such a program, both in the USA [6] and in Europe [7] and in our own country [8] . According to the latest data available, in Italy approximately 70% of patients after coronary or valvular heart surgery are admitted to CPR programs, but only 15% of patients following an acute myocardial infarction (AMI), whether or not treated with percutaneous revascularization (PTCA) and less than 5% of patients who have undergone elective PTCA [9] . Therefore, many patients are referred directly to primary care upon discharge and often (due to the progressively shorter length of stay in acute wards) they are discharged without an adequate assessment of the residual risk of coronary heart disease and progression of atherosclerosis, with incomplete treatment (as regards the therapeutic targets defined by current scientific evidence) and without any structured intervention to ensure the long term adherence to treatment and maintenance of adequate life styles.
Furthermore, concerning the role of CRP in the management of patients with ischemic heart disease after revascularization, there are no data, at least in our country [10] , on which patients, after aortocoronary bypass (CABG) but particularly after primary or elective PTCA, are admitted to a CRP program. In other words, it is not known if in clinical practice a management bias exists that reserves structured CRP intervention only to a specific subgroup of patients (those with complications? with comorbidities? male gender? younger patients? elderly?).
Similarly there are no data on whether patients admitted to CRP receive treatment with respect to the current guidelines and whether they are discharged in a more adequate condition to achieve an effective secondary prevention in the short-medium term. Recently the GOSPEL study carried out on more than 3,000 patients after recent AMI (65% of whom underwent revascularization: 41% PTCA and 27% CABG) showed, after a comprehensive CRP program (including a series of contacts and monthly clinical controls in the first 6 months, followed by 6-monthly controls for 3 years), an improvement in functional capacity and quality of life, a better adherence to pharmacological treatment and life style modifications, and a reduction in the global cardiovascular risk profile and subsequent coronary events, i.e. a significant reduction of AMI [11] . The results of this study however refer to a healthcare model that is not adopted in current clinical practice (and, realistically speaking, is not feasible), and the results of the few studies in the literature on the short and medium term effects of a CRP intervention on the same end-points are controversial [12] [13] [14] [15] [16] [17] .
Finally, data are also controversial on the shortmedium term efficacy and sustainability of various post intensive rehabilitation care models, ranging from the "spot" model in post-acute care without any follow-up reinforcement program, to one with a periodic follow-up carried out at a rehabilitation center [11] [12] [13] [14] [15] [16] [17] [18] .
In the light of these considerations, following on the heels of the Italian Survey on Cardiac Rehabilitation (ISYDE-2008) carried out by the Italian Association for Cardiac Prevention and Rehabilitation (Gruppo Italiano di Cardiologia Riabilitativa e Preventiva -GICR) and following the call for action of the European Society of Cardiology (ESC) on the implementation of guidelines of cardiovascular prevention, the GICR considers it useful to conduct a survey to systematically gather accurate information aimed to define in the "real world" the characteristics of ischemic heart disease patients with coronary revascularization who are admitted to CRP programs, and what interventions and treatments are carried out, to verify in the short-medium term the adherence to such treatments and to what extent the recommended targets are pursued, and evaluate the correlation of these aspects with events and healthcare costs. The survey does not intend to modify the models of intervention and follow-up adopted by the single participating centers.
Methods

Study design
The Italian survey on cardiac rehabilitation and secondary prevention after cardiac revascularization (ICAROS) is a prospective, longitudinal, multicentric survey, with on-line web-based data collection. Its design corresponds to the survey's goal, i.e. to describe accurately in the Italian cardiological setting, through a representative number of CR centers belonging to the GICR national network, the characteristics, content and effects in the medium term of CRP inpatient or outpatient programs offered to patients after CABG or PCTA. The survey does not involve any experimentation of drugs or any diagnostic tests, care interventions or pharmacological treatments that are not part of the clinical practice and rehabilitation protocols routinely adopted by each single cardiologist/participating center (and which will be registered in the data base). Patients' anonymity will be guaranteed.
Aims
The primary aims of the study are: 1. to define the principal clinical characteristics of patients who have undergone PTCA or CABG and have been admitted to a CRP program; 2. to identify the components of the CRP programs in terms of diagnostic procedures and assessment tests performed, treatments administered, educational programs and physical exercise interventions employed (from individual treatments aimed at the recovery of functional autonomy to physical training); 3. to identify and analyze drug treatments prescribed at discharge from the acute facility and those prescribed at the end of the CRP program; 4. to verify the clinical outcome during the course of the CRP program and at 6 months and 1 year as well as patients' adherence to the prescribed pharmacological therapy and to the recommended life styles, and the achievement and maintenance of the targets in relation to the modifiable risk factors; 5. to define the consumption of major healthcare resources (major cardiac events, hospital re-admission, emergency care access, specialist visits) during the first year following a CRP program.
Population
The survey population will consist of all patients consecutively discharged in the period November 3 -30, 2008 at the end of an inpatient, day-hospital or outpatient CRP program after CABG (isolated or associated to valve or ascending aorta surgery) or PTCA (rescue, primary or elective).
There are no age, sex or other patient selection criteria. In order to evaluate in the clinical praxis the real distance from the revascularisation procedure and access to CPR, there will be no limitation of time from the index event. Patients who died during the course of rehabilitation or were transferred-hospitalized for acute clinical recurrences (data will in any case be collected), patients after combined valvular and coronary surgery for preoperatory detection of asymptomatic coronary heart disease, patients with unfavorable prognosis at 1 year for any reason, and finally patients who did not give their informed consent to participate will be excluded from the survey.
Selection of participating centers
The process of identification of the CR centers invited to participate in the ICAROS study was based on the results of the study ISYDE-2008 [8] and the selection criteria applied were as follows: -analysis of the core components of the center's rehabilitation program in conformity with national CRP guidelines [3] , -the center's recruitment potential, quantified as at least 15 patients who completed the inpatient, day-hospital or outpatient CRP program in the two-week study period of ISYDE-2008.
In selecting the Centers attention was paid to ensure an adequate representativity in terms of hospital organization, territorial distribution (metropolitan or not; north, central or southern Italy) and care setting (inpatient, day-hospital, outpatient).
Sample size
In view of the study design it is not possible to determine the sample size a priori. However, based on ISYDE 2008 [8] data analysis, we plan to recruit approximately 1300-1400 patients, 75% of whom with post CABG diagnosis and 25% with post PTCA diagnosis. This sample size is adequate from a statistical point of view with respect to the study aims and methods of data analysis.
Methods and mode of data collection and data quality control
ICAROS is a prospective survey with a duration of 4 weeks that will collect data on patients consecutively discharged after a first cycle of rehabilitation following surgical or percutaneous revascularization. A follow-up contact at 6 and at 12 months is planned. Data collection will be through completion of an electronic survey form (e-CRF) on-line in a dedicated section of the GICR website www.gicr.it. Access to the electronic survey forms will be restricted to the investigators previously identified by the study's Executive Committee according to the indications of the director of each participating center. The on-line data collection instrument is available for use round-the-clock and the data required for patients can be inserted in real-time, at any moment during the course of the survey.
The data collection masks will be structured with questions and multiple choice answers pre-ordered and with obligatory exits, in order to optimize the classification of the various items, reserving for a later detailed analysis the evaluation of less typical or less frequently observed situations. An on-line guide for the compilation of the fields is envisaged.
An on-line and telephone help-desk will also be available throughout the duration of the study to resolve or clarify any technical or clinical problems.
The Executive Committee is responsible for the control of data quality, and will generate eventual enquiries related to questions of incomplete or inconsistent data.
Data collection is structured in such a way as to prevent in any way tracing the identity of the subjects whose rehabilitation course is described in the survey. Concerning the structural and organizational data of the participating Centers, the GICR and its corresponding administrative office will manage the ownership and treatment of the data collected in full respect of the current national privacy act.
Data collection form and follow-up (Table 1)
The e-CFR form is designed to cater for the collection and analysis of data regarding both the participating centers (each center's structural and organizational characteristics) and patients: i.e. each patient's anthropometric, demographic and social data, 
Follow-up
At 6 and 12 months (±15 days) the following information will be collected from the same patients, by telephone interview with each patient, conducted according to a standard relational model and not linked to other eventual visits that may be programmed by the Center: 1. Life style: smoking habit, dietary habit (measured with a specific scale), physical activity (measured by means of a specific scale). 2. Target: knowledge or not and usual values of BP < 140/90 (and <= 130/80 in diabetic subjects), LDL <100 (and <80), glycosylated hemoglobin in diabetics <7%. 3. In the case of a subsequent visit to the Center: precise values of BP, HR, BMI, waist measurement, lipid profile, fasting glucose, glycosylated hemoglobin in diabetics. 4. Pharmacological therapy: active agents, dosage, incidental contraindications and adverse events influencing the non prescription/withdrawal from treatment, qualitative assessment of adherence (evaluated with a specific questionnaire). 5. Events:
-Death for any cause -Cardiovascular death -Non-fatal AMI -new (including "programmed") revascularization -re-hospitalization for cardiovascular causes (heart failure, angina, pacemaker, ICD and RCT) -fatal and non fatal cerebrovascular events -Emergency Care access without subsequent hospital admission -visits carried out/planned by the Center's follow-up program. 6. Diagnostic procedures: echocardiogram, exercise test, Holter ECG or blood pressure monitoring, nuclear scan, coronary angiography, coronary multislice-CT. 7. Drop-outs (i.e. patients lost to follow-up).
comorbidities and global risk profile, clinical data (related to the index event and rehabilitation phase) as regards complications, physical examination, and treatment, exercise training and pharmacological care. Information is gathered also on the duration of the post-acute rehabilitation program and on the type of follow-up program routinely adopted by the center.
At 6 and 12 months, information will be collected from the patients, through telephone interview conducted according to a standard relational model and not linked to other visits programmed by the Center, on: life styles adopted, the achievement or not of the therapeutic targets [blood pressure (BP), lipid profile, body mass index (BMI], pharmacological treatment (active agents and adherence), cardiovascular events, and on the healthcare resources consumed.
Statistical considerations
Apart from the overall analysis of end-points, data will be analyzed according to the revascularization strategy (CABG or PTCA), the sex and age of patients, the rehabilitation setting and the follow-up time intervals.
Ethical aspects and good medical practice
The protocol will be submitted for approval to the local Ethical Committee of each center participating in the Survey.
Notwithstanding the purely observational design of study, an informed consent will be obtained from each patient to authorize the treatment, in total anonymity, of patients' clinical data held in a centralized data-base.
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